Written by Dr. Dixit Kumar Thakur
I am Dr. Dixit Kumar Thakur, Senior Pulmonologist at Pulmovista Clinics, Delhi. Of all the patients I see at my clinic, the ones who stay with me longest are the children — and the parents who bring them, often exhausted and frightened after months or years of watching their child struggle to breathe.
Childhood asthma in Delhi is not just more common than in other Indian cities — it is more complex, more challenging to manage, and more consequential if undertreated. Delhi’s air quality, the density of allergens in our homes and schools, and the year-round exposure to pollution-driven airway irritation create an asthma environment for Delhi children that demands a level of specialist attention that most families are not receiving.
This guide is written directly to the parents of children with asthma in Delhi. I will explain how childhood asthma differs from adult asthma, why Delhi’s environment makes it worse, how I diagnose it accurately at Pulmovista Clinics, and what the best asthma treatment in Delhi for children looks like in 2026 — from the first inhaler to the most advanced therapies available. I will answer the questions parents most often bring to my clinic. And I will be honest about what we know, what we don’t know, and what you can do right now to protect your child’s lungs.
1. A Father’s Perspective, A Doctor’s Training: Why I Take Childhood Asthma Personally
I want to be transparent about something that shapes how I approach childhood asthma at Pulmovista. I am a father. I have watched my own child struggle with respiratory symptoms during Delhi’s worst pollution days. I have felt that particular combination of medical knowledge and parental helplessness — knowing exactly what is happening in the airways while being unable to simply make it stop.
That experience has made me a better paediatric asthma doctor. It has taught me that parents do not need jargon — they need clarity. They do not need dismissal — they need to be believed when they say their child’s breathing is not right. And they do not need minimal intervention — they need a specialist who takes childhood respiratory disease in Delhi as seriously as the evidence demands it should be taken.
At Pulmovista Clinics, every child with asthma receives the same level of clinical attention I would want for my own child: a thorough assessment, an objective diagnosis, a personalised treatment plan, and a long-term specialist relationship that grows with them as their condition evolves and Delhi’s environment continues to challenge their lungs.
| “Every parent who brings a child to Pulmovista is doing the most important thing they can do for their child’s respiratory health: seeking specialist input early. The children whose asthma I worry about are not the ones in my clinic. They are the ones whose parents were told ‘children often grow out of asthma’ and sent home with a blue inhaler and no follow-up plan.” — Dr. Dixit Kumar Thakur, Pulmovista Clinics, Delhi |
2. Why Delhi Is Especially Hard on Children’s Lungs
Children’s lungs are not small adult lungs — they are fundamentally different organs in a critical developmental phase. Human lungs continue developing until the mid-20s. The lung capacity, the airway architecture, and the alveolar surface area that a person will carry for the rest of their life are laid down during childhood. Anything that interferes with that development — and Delhi’s air quality does so aggressively — causes consequences that extend far beyond childhood.
How Delhi’s Pollution Harms Children’s Developing Lungs
• Higher respiratory rate: Children breathe faster than adults — 20–30 breaths per minute in a young child versus 12–16 in a healthy adult. This means children inhale proportionally more PM2.5 per kilogram of body weight for the same outdoor exposure duration.
• Narrower airways: A child’s airways are narrower relative to their body size. The same degree of airway inflammation or mucus production that causes mild breathlessness in an adult can cause severe airflow obstruction in a child — making asthma attacks more rapid in onset and more dangerous.
• Impaired lung growth: Delhi-based studies have documented that children living in high-pollution areas have FEV₁ and FVC values significantly below predicted for their age, height, and sex — a permanent deficit in lung capacity that will accompany them into adulthood.
• Increased sensitisation risk: Early and heavy exposure to allergens — dust mites, cockroach, Aspergillus, Prosopis pollen — during the immunological window of early childhood increases the risk of developing IgE-mediated allergy and allergic asthma. Delhi’s year-round high allergen load makes sensitisation more likely and earlier than in cleaner environments.
• School exposure amplifies risk: Delhi’s schools — even in well-maintained private schools — have outdoor play areas where children are exposed to peak pollen counts in spring and dust during andhi events. The school environment is an important amplifier of the domestic allergen and pollution exposure children already experience at home.
| Age Group | Specific Concerns for Delhi Children with Asthma |
| Infants and toddlers (0–2 years) | Virus-triggered wheeze — RSV and rhinovirus are the dominant trigger; distinguishing asthma from viral bronchiolitis requires specialist assessment; inhaler devices must include spacer with mask |
| Pre-school (2–5 years) | Episodic viral wheeze vs. true asthma — the distinction requires a therapeutic trial and careful clinical monitoring; dust mite and cockroach sensitisation typically first identifiable at this age |
| School age (5–12 years) | Exercise-induced bronchoconstriction becomes prominent — PE class and outdoor play during pollution events are major triggers; spirometry becomes reliable from age 5–6; FeNO testing feasible; school action plan essential |
| Adolescents (12–18 years) | Adherence crisis — teenagers resist inhalers due to embarrassment; sports participation is important but must be managed; puberty hormone changes affect asthma control; transition to adult services needs planning |
3. How I Diagnose Asthma in Children at Pulmovista Clinics
Diagnosing asthma in children — particularly in younger children — is one of the most clinically nuanced challenges in paediatric respiratory medicine. Unlike adults, children cannot always articulate their symptoms accurately. Young children cannot perform spirometry. And the condition that ‘looks like’ asthma in a toddler may be a transient viral wheeze that resolves without treatment — or it may be the first presentation of lifelong asthma that requires early, aggressive management to prevent airway remodelling.
At Pulmovista Clinics, I tailor my diagnostic approach to the child’s age, using every available tool appropriate to their developmental stage:
For Children Under 5 — Clinical Diagnosis and Therapeutic Trial
Spirometry is not reliable in children under 5 — most cannot sustain the forced exhalation required for accurate measurement. My diagnosis in this age group is based on:
• Clinical history: Pattern of wheeze — Is it episodic (viral-triggered) or persistent? Does it occur between colds? Is there a nocturnal component? Is there a family history of atopy?
• Response to bronchodilator: A clear clinical response to inhaled Salbutamol via spacer strongly supports airway reversibility consistent with asthma.
• Therapeutic trial: A 6–8 week trial of low-dose ICS — with objective assessment of symptom frequency, rescue inhaler use, and exercise tolerance before and after — is the most practical diagnostic tool in this age group.
• Allergy testing: Skin prick testing is feasible from age 2 onwards at Pulmovista Clinics. A positive test to dust mite, cockroach, or moulds in a wheezing child strongly supports an atopic, asthma-associated aetiology.
For Children 5 Years and Above — Objective Diagnostic Tests
• Spirometry with bronchodilator reversibility: The gold standard from age 5–6, when children can reliably perform the forced exhalation manoeuvre. At Pulmovista Clinics, our paediatric spirometry team is trained in child-friendly techniques that make the test accessible and accurate even for anxious or young school-age children.
• FeNO (Fractional Exhaled Nitric Oxide): A 10-second quiet exhalation — non-invasive, effortless, and highly informative. FeNO measures eosinophilic airway inflammation — elevated results in a symptomatic child strongly support allergic asthma and predict good response to ICS therapy.
• Peak flow diary: Home peak flow monitoring over 2–4 weeks identifies the variability in airflow that is the hallmark of asthma — and in Delhi, frequently reveals pollution-correlating patterns (worse on high-AQI days, better on weekends when outdoor activity is reduced).
• Exercise challenge: For children with suspected exercise-induced bronchoconstriction — a supervised exercise test with pre- and post-exercise spirometry at Pulmovista Clinics confirms the diagnosis and quantifies the severity.
Conditions I Rule Out Before Diagnosing Childhood Asthma at Pulmovista
Not all childhood wheeze is asthma. At Pulmovista Clinics, I systematically consider and exclude:
• Viral bronchiolitis: The most common cause of wheeze in children under 2 — RSV-driven, usually self-limiting, does not respond to bronchodilators as definitively as asthma.
• Inhaled foreign body: A missed foreign body inhalation can present as persistent wheeze with unilateral air trapping — easily missed without chest X-ray and high clinical suspicion.
• Primary ciliary dyskinesia (PCD): Recurrent respiratory infections from infancy, persistent productive cough — referred for specialist nasal brushing biopsy if suspected.
• Vocal cord dysfunction (VCD): Paradoxical vocal cord adduction during inspiration — mimics exercise-induced asthma in adolescents; important to distinguish because treatment is laryngological, not respiratory.
• Gastro-oesophageal reflux: GERD-triggered cough and wheeze in infants and young children — addresses the lower oesophageal mechanism rather than airways.
4. Delhi’s Childhood Asthma Triggers: What I Tell Every Parent at Pulmovista
Once asthma is confirmed, the most important clinical task is identifying the specific triggers driving your child’s disease. In Delhi, this is not a generic list — it is a hyperlocal, season-specific profile that I build individually for every Pulmovista child patient based on their allergy testing, their symptom pattern, and their living and school environment.
The Most Important Triggers for Delhi Children With Asthma
| Trigger | Why It Matters in Delhi | What I Advise Parents at Pulmovista |
| House dust mite | Most prevalent perennial allergen in Delhi; worst July–October (monsoon humidity); lives in mattress, pillows, upholstered sofa | Anti-mite mattress and pillow covers; wash bedding weekly at ≥60°C; HEPA air purifier in child’s bedroom; no stuffed toys on the bed |
| Cockroach allergen | Highly prevalent in Delhi apartments; strongly associated with asthma in urban Indian children; year-round exposure | Pest control; seal kitchen entry points; store food in airtight containers; clean food surfaces immediately |
| Delhi PM2.5 | Year-round but worst Oct–Feb and April–May; impairs mucociliary clearance; drives steroid-partial resistance | HEPA purifier in child’s room; N95 mask for outdoor exposure on AQI >200; keep children indoors on AQI 300+ days |
| Viral respiratory infections | RSV, rhinovirus, influenza — the most common acute asthma trigger in children; frequent in Delhi’s crowded schools | Annual influenza vaccine for all asthmatic children; hand hygiene education; early recognition of virus-triggered worsening |
| Exercise | Physical education and outdoor play are important for health but trigger bronchoconstriction in poorly controlled asthma | Pre-exercise rescue inhaler; monitor on high-pollution days; move PE indoors on AQI 200+ days; correct treatment makes most exercise possible |
| Prosopis pollen (April–May) | Lines South and Central Delhi roads; peak April; causes immediate bronchoconstriction in sensitised children | Window closure during pollen season; antihistamine pre-medication from March; avoid outdoor play between 6am–10am in April |
| Alternaria mould | Post-monsoon peak; thunderstorm asthma risk; strongly associated with severe asthma attacks in children | Come indoors before thunderstorms in pre-monsoon season; dehumidify home; emergency plan reviewed before monsoon each year |
| Tobacco smoke | Passive smoke exposure — from parents, relatives, household members — dramatically worsens childhood asthma | Complete smoking ban inside the home and car; family members must smoke away from the child at all times — no exceptions |
| ⚠ A Direct Message to Smoking Parents from Dr. Dixit Kumar Thakur I am going to say this directly, because I owe it to your child: if you or any household member smokes inside your home, in your car, or near your asthmatic child — you are making their disease worse. Every cigarette smoked around a child with asthma increases airway inflammation, reduces the effectiveness of their inhalers, and increases their risk of a severe, potentially life-threatening attack. At Pulmovista Clinics, I provide full smoking cessation support — including pharmacological therapy — for all smoking parents of asthmatic children. I do this not as a judgment, but because it is the single most impactful thing some families can do for their child’s respiratory health. Please talk to me about it at your next Pulmovista appointment. |
5. Asthma Medications for Children: What I Prescribe and Why
One of the most common anxieties parents bring to Pulmovista Clinics is about asthma medications — particularly inhaled corticosteroids. ‘Will steroids stunt my child’s growth?’ ‘Is it safe to give a 4-year-old an inhaler every day?’ ‘Why can’t we just use the blue inhaler when needed?’ I address these concerns directly, because a parent who is anxious about a medication will not give it consistently — and inconsistent medication is the primary cause of poor asthma control in children.
The Most Important Question I Answer First: Are Inhaled Steroids Safe for My Child?
Yes. This is the question I am asked most frequently at Pulmovista by parents of asthmatic children — and the answer is unequivocal. Inhaled corticosteroids (ICS) at appropriate doses for childhood asthma are safe, well-tolerated, and do not cause the systemic side effects associated with oral steroids. The evidence on growth is clear: low-to-medium dose ICS therapy produces a negligible, clinically insignificant effect on final adult height — measured in millimetres — that is vastly outweighed by the harm of uncontrolled asthma on lung development, quality of life, and school attendance.
Uncontrolled asthma — with its repeated inflammation, airway remodelling, and exacerbations — causes far more lung damage than correctly dosed ICS therapy. The fear of the medication should never exceed the fear of the undertreated disease.
GINA 2026 Treatment Framework for Childhood Asthma at Pulmovista
| GINA Step / Age Group | Dr. Dixit Kumar Thakur’s Preferred Treatment at Pulmovista |
| Step 1 — Mild intermittent asthma (children ≥6 years) | As-needed low-dose ICS-formoterol (budesonide-formoterol) — GINA 2026 first-line. Replaces SABA-only rescue. Every rescue puff delivers anti-inflammatory ICS. |
| Step 1 — Children under 6 years | As-needed SABA via spacer with mask (Salbutamol); consider low-dose ICS trial if frequent episodes; avoid SABA-only in atopic children |
| Step 2 — Mild persistent (all ages) | Daily low-dose ICS + as-needed SABA. For ≥6 years: consider as-needed ICS-formoterol as an alternative to daily ICS. Leukotriene antagonist (montelukast) as alternative for rhinitis comorbidity. |
| Step 3 — Moderate persistent (≥6 years) | Low-dose ICS-LABA (e.g. budesonide-formoterol SMART) as preferred strategy. Add montelukast for allergic rhinitis overlap. |
| Step 4 — Severe persistent (≥6 years) | Medium-high dose ICS-LABA. Add tiotropium as LAMA add-on where approved. Refer to Pulmovista Clinics for specialist step-up assessment. |
| Step 5 — Refractory severe (≥6 years) | Biologic therapy assessment. Omalizumab approved from age 6; Dupilumab from age 6; Mepolizumab from age 6; Benralizumab from age 12; Tezepelumab from age 12. Full biomarker assessment at Pulmovista. |
Inhaler Devices: Matching the Device to the Child’s Age
The best medication in the wrong device is ineffective medication. Inhaler device selection for children is one of the most important prescribing decisions I make at Pulmovista — and one of the areas where paediatric asthma management most frequently goes wrong in general practice:
| Age Group | Correct Inhaler Device at Pulmovista |
| 0–3 years | pMDI (pressurised MDI) + spacer with face mask. No other device is appropriate. Babies and toddlers cannot coordinate breath actuation. |
| 3–5 years | pMDI + spacer with mouthpiece (replacing mask when child can form a seal). Assess seal at Pulmovista — some 3-year-olds manage a mouthpiece, others need the mask until 4–5. |
| 5–7 years | pMDI + spacer — preferred. Some children in this age group can begin to use a breath-actuated MDI. Spirometry at Pulmovista confirms whether inspiratory flow is adequate for DPI. |
| ≥8 years | DPI (dry powder inhaler) — most 8-year-olds can generate sufficient inspiratory flow. Budesonide-formoterol Turbuhaler for SMART therapy. Verify technique at every Pulmovista appointment. |
| All ages | Inhaler technique assessed at EVERY Pulmovista appointment — not assumed to be maintained between visits. Parents and children both learn the technique so home supervision is possible. |
6. The School Plan: What Every Delhi School Needs to Know About Your Child’s Asthma
One of the most practically important documents I create for every school-age child at Pulmovista Clinics is a written School Asthma Action Plan — because a child spends more waking hours at school than anywhere else, and a school that does not know how to respond to an asthma attack is a school that cannot keep your child safe.
| ✔ Pulmovista Clinics School Asthma Plan — What Every Delhi School Must Know ✔ Child’s name, class, teacher, and Pulmovista Clinics emergency contact number ✔ Current asthma medications and doses — including which inhalers are for daily use and which for rescue ✔ Written instructions for how to recognise a worsening asthma episode at school ✔ Step-by-step rescue protocol: how many Salbutamol puffs to give, at what intervals, and when to call an ambulance ✔ Specific Delhi triggers relevant to this child — e.g. ‘Keep indoors during dust storms’; ‘Do not allow outdoor PE on AQI >200 days’ ✔ Location of the child’s spare rescue inhaler — must be accessible immediately, NOT locked in a cabinet or left in a bag ✔ Whether the child can self-administer their inhaler (typically from age 8–9 with demonstrated competence) or requires adult assistance ✔ Parent and Pulmovista Clinics contact details for emergency At Pulmovista Clinics, this plan is provided in both English and Hindi upon request, and updated at every annual review. |
Exercise and Sports: What I Tell Parents About Their Child’s Activity
One of the most damaging things parents sometimes do — with entirely good intentions — is restrict their asthmatic child’s physical activity out of fear of triggering an attack. This protectiveness is understandable but counterproductive: regular physical activity is essential for lung development, cardiovascular health, and mental wellbeing in asthmatic children — and well-controlled asthma should not prevent participation in most sports.
At Pulmovista Clinics, my goal for every school-age asthmatic child is to ensure that their treatment is optimised to the point where they can participate fully in physical education and outdoor activities on normal-AQI days. The steps that make this possible:
• Optimise daily controller therapy: A child who is on the correct daily ICS or SMART therapy and using it correctly will have significantly less exercise-induced bronchoconstriction than one who is only using a rescue inhaler.
• Pre-exercise rescue inhaler: For children with residual exercise-induced bronchoconstriction despite optimal controller therapy — 2 puffs of Salbutamol via spacer 15 minutes before exercise provides reliable protection.
• Montelukast add-on: For children whose exercise-induced symptoms are driven by the leukotriene pathway — common in allergic asthmatic children — daily montelukast significantly reduces exercise-induced bronchoconstriction.
• AQI-aware activity planning: On days with AQI above 200, outdoor exercise should be moved indoors or replaced with low-intensity indoor activity. On AQI 300+ days, no outdoor exercise under any circumstances.
7. Biologic Therapy for Children: When Standard Asthma Treatment Is Not Enough
For a small but important group of children with severe, uncontrolled asthma — those who continue to have frequent attacks, hospital admissions, and significant activity limitation despite optimised standard therapy — biologic therapy represents a genuinely life-changing treatment option. As the best asthma treatment in Delhi for hard-to-treat childhood cases, biologic therapy at Pulmovista Clinics has transformed outcomes for children whose families were told ‘this is just how bad their asthma is.’
Which Children May Qualify for Biologic Therapy?
At Pulmovista Clinics, I assess children for biologic therapy eligibility when:
• Age 6 or above — biologic therapies are approved from different minimum ages depending on the specific agent
• Severe persistent asthma despite optimal high-dose ICS-LABA therapy, correctly used
• 2 or more severe exacerbations in the past 12 months requiring oral steroids, ER visits, or hospitalisation
• Significant activity limitation, frequent school absence, or severe quality-of-life impairment from asthma
• Elevated biomarkers: blood eosinophils ≥300 cells/µL, total IgE elevated with allergen sensitisation, FeNO >25 ppb
Biologic Agents Approved for Paediatric Asthma at Pulmovista
| Biologic Agent | Age Approved | Target / Best for |
| Omalizumab (Xolair) | ≥6 years | Severe allergic asthma with elevated IgE — most common in Delhi’s dust mite + pollen sensitised children |
| Mepolizumab (Nucala) | ≥6 years | Severe eosinophilic asthma — blood eosinophils ≥300 cells/µL |
| Dupilumab (Dupixent) | ≥6 years | Type 2 asthma + atopic dermatitis or nasal polyps — common in atopic Delhi children |
| Benralizumab (Fasenra) | ≥12 years | Severe eosinophilic asthma — rapid eosinophil depletion; 8-weekly maintenance |
| Tezepelumab (Tezspire) | ≥12 years | Broadest eligibility — effective across all severe asthma phenotypes |
| “I had a 9-year-old patient at Pulmovista — severe allergic asthma, sensitised to dust mite and Alternaria. She had been hospitalised twice in the previous year. Her parents had stopped sending her to school on bad air days, taken her out of the school play, and were contemplating moving cities. Six months after starting Omalizumab, she had not been hospitalised once. She was attending school every day. She performed in the school annual function. That is what the right biologic can do for a child. And it is what I want for every eligible child who comes to Pulmovista.” — Dr. Dixit Kumar Thakur, Pulmovista Clinics, Delhi |
8. The Delhi Parent’s Seasonal Action Plan for Asthmatic Children
One of the most valuable things I provide at Pulmovista Clinics is a personalised seasonal action plan for asthmatic children — because in Delhi, every season brings a different combination of triggers that demands a different management response. Here is my seasonal framework for Delhi parents:
| Season / Month | Key Risks & Dr. Thakur’s Action Plan for Parents |
| Oct–Feb (Winter) | PM2.5 inversions; cold air bronchospasm; viral infections; influenza peak. Ensure annual flu vaccine given in September. Confirm controller inhaler is optimised before November. HEPA purifier in child’s bedroom running nightly. N95 mask for outdoor exposure on AQI >200. |
| Nov–Dec (Stubble + Diwali) | Worst pollution weeks of the year. School absent on AQI 300+ days — no exceptions. Standby oral steroid prescription reviewed with Dr. Thakur before Diwali. Emergency plan rehearsed with child and spouse. |
| Feb–May (Pollen + Dust Storm) | Prosopis and mulberry pollen; andhi season from April. Start antihistamine from March if pollen-sensitised. Close school windows during storms; PE indoors on andhi days. Child comes indoors immediately on any dust storm warning. |
| June–Sept (Monsoon) | Mould explosion; Alternaria and Aspergillus peak; thunderstorm asthma risk. Dehumidify home. Come indoors before thunderstorms. Review emergency plan before monsoon. Annual mould inspection of AC units and bathrooms. |
| Year-round | Dust mite exposure; cockroach allergen; passive smoke; viral infections. Anti-mite mattress covers always in place. Complete smoking ban in home and car. Annual Pulmovista review and spirometry update. School action plan updated at start of each academic year. |
9. Why Delhi Parents Choose Pulmovista Clinics for the Best Asthma Treatment in Delhi for Their Children
Parents seeking the best asthma treatment in Delhi for their children choose Pulmovista Clinics because of the depth of specialist care, the child-friendly clinical environment, and the long-term relationship that Dr. Dixit Kumar Thakur builds with every young patient and their family. Here is what makes Pulmovista the right choice for your child:
1. Paediatric asthma expertise: I have diagnosed and managed childhood asthma across all age groups and severity levels — from wheezing infants to adolescents with severe, treatment-refractory disease — for over 13 years. My clinical experience with Delhi’s specific childhood asthma profile is extensive and continuously updated against GINA 2026.
2. Age-appropriate diagnostic testing: Child-friendly spirometry from age 5; FeNO from age 4; skin prick allergy testing from age 2; peak flow monitoring with child-appropriate targets. Every test at Pulmovista is adapted to the child’s age, developmental stage, and anxiety level.
3. GINA 2026 paediatric protocols: All medication prescriptions at Pulmovista are aligned with the most current GINA 2026 paediatric guidelines — including the shift away from SABA-only therapy that has not yet reached most Delhi general practices.
4. Biologic therapy for children: Pulmovista Clinics offers the full range of biologic therapies approved for paediatric asthma — Omalizumab, Mepolizumab, and Dupilumab from age 6; Benralizumab and Tezepelumab from age 12. Complete biomarker eligibility assessment is conducted before any biologic is prescribed.
5. Written School Asthma Action Plan: Every school-age Pulmovista patient receives a written, personalised school action plan — in both English and Hindi on request — updated at every annual review.
6. Parent education as a clinical priority: At Pulmovista, I spend as much time with the parents as with the child. Understanding what asthma is, why the controller inhaler matters even on symptom-free days, how to recognise worsening, when to escalate, and when to go to hospital — this knowledge, given to parents in a clear and non-judgmental way, is one of the most powerful interventions available.
7. Long-term specialist relationship: Childhood asthma changes as children grow — triggers shift, lung function develops, medication requirements evolve, and the adolescent who needs to self-manage brings new challenges. At Pulmovista, I commit to a long-term clinical relationship with every child patient — not a one-off consultation.
Conclusion: Your Child’s Lungs Are Worth Fighting For — Pulmovista Clinics Is Here
Childhood asthma in Delhi is a serious condition in a uniquely challenging environment. The pollution is real. The allergen burden is real. The risk to developing lungs is real. And the gap between the treatment most children are currently receiving and the treatment that is possible with proper specialist care is real — and closes every time a parent brings their child to Pulmovista Clinics.
From the first wheezing episode to the school-age child who keeps missing PE class to the teenager whose severe asthma needs biologic therapy — every stage of childhood asthma can be managed better than it typically is in Delhi. Better inhaler technique. Better allergen control. Better medication alignment with GINA 2026. And where needed, access to the biologic therapies that transform outcomes for children whose asthma has outgrown standard treatment.
As both a father and a doctor, I commit to giving your child the best asthma treatment in Delhi that evidence and clinical experience can provide — at Pulmovista Clinics, and in every consultation we share together.
FAQs-Childhood Asthma in Delhi
- My 3-year-old wheezes every time he gets a cold. Does he definitely have asthma?Not necessarily — and this is one of the most important distinctions I make at Pulmovista Clinics. Episodic viral wheeze — where a child wheezes only during respiratory infections and is completely well between illnesses — is extremely common in young children and frequently resolves by school age. True asthma involves persistent or recurrent symptoms beyond the context of acute viral infections, and is more likely when there is a strong family history of atopy, when the child has eczema or allergic rhinitis, and when wheeze is triggered by allergens or exercise as well as viruses. I assess both patterns carefully at Pulmovista — because the management approach differs significantly.
- My daughter is 7 and has been on a daily steroid inhaler for 2 years. Are there long-term effects I should worry about?At low-to-medium doses appropriate for childhood asthma, inhaled corticosteroids have an excellent long-term safety profile. The concern about growth suppression is real but quantitatively small — studies show a reduction in final adult height of approximately 1cm or less with low-dose ICS therapy — and this needs to be weighed against the documented harm to lung development from uncontrolled asthma. Oral thrush is prevented by rinsing the mouth after each dose. Systemic steroid effects — adrenal suppression, bone density reduction, cataract — do not occur at standard ICS doses for childhood asthma. At Pulmovista Clinics, I review all children on ICS annually to ensure they are on the minimum effective dose, stepping down when control allows.
- My son's asthma only seems bad in October and November. Does he need year-round medication?Seasonal worsening — particularly October–November in Delhi, when stubble burning and Diwali coincide — is extremely common in asthmatic children. But seasonal severity does not mean the asthma is absent at other times. The underlying airway inflammation of asthma is typically present year-round — it is simply amplified to clinical severity during the worst pollution and allergen periods. At Pulmovista Clinics, I use spirometry and FeNO to measure baseline airway inflammation between the worst seasons. If these show significant residual inflammation even in 'good' months, year-round controller therapy is indicated — because each October without adequate protection risks another severe exacerbation.
- Can my child outgrow asthma?Some children do experience remission of asthma symptoms during or after puberty — a process historically described as 'growing out of asthma.' However, the reality is more nuanced. What typically happens is that lung function growth during puberty temporarily outpaces the degree of airway obstruction, reducing symptoms. But the underlying airway hyper-reactivity and sensitisation often persist — and symptoms frequently recur in adulthood, particularly with triggers like smoking, pregnancy, or occupational exposures. At Pulmovista, I advise parents not to discontinue asthma monitoring or medication without a formal specialist review confirming sustained remission — because assuming the asthma has 'gone' leads to unnecessary exacerbations when it returns.
- How do I book a childhood asthma assessment at Pulmovista Clinics?You can book a paediatric asthma consultation with Dr. Dixit Kumar Thakur at Pulmovista Clinics by visiting www.pulmovista.com or calling the clinic directly. When booking, please mention your child's age and current medications — this helps me arrange age-appropriate tests (spirometry, FeNO, allergy testing) at or before the appointment. If your child has had a recent hospital admission or severe exacerbation, please request an urgent appointment. Both in-person and teleconsultation options are available for initial assessment.
